Your browser doesn't support javascript.
loading
PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancer.
Santiago-Gómez, Angélica; Kedward, Thomas; Simões, Bruno M; Dragoni, Ilaria; NicAmhlaoibh, Roisin; Trivier, Elisabeth; Sabin, Verity; Gee, Julia M; Sims, Andrew H; Howell, Sacha J; Clarke, Robert B.
Afiliación
  • Santiago-Gómez A; Breast Biology Group, Manchester Breast Centre, Division of Cancer Sciences, Oglesby Cancer Research Building, University of Manchester, Manchester, M20 4GJ, United Kingdom.
  • Kedward T; Breast Biology Group, Manchester Breast Centre, Division of Cancer Sciences, Oglesby Cancer Research Building, University of Manchester, Manchester, M20 4GJ, United Kingdom.
  • Simões BM; Breast Biology Group, Manchester Breast Centre, Division of Cancer Sciences, Oglesby Cancer Research Building, University of Manchester, Manchester, M20 4GJ, United Kingdom.
  • Dragoni I; Cancer Research UK's Commercial Partnerships Team, London, EC1V 4AD, United Kingdom.
  • NicAmhlaoibh R; Cancer Research UK's Commercial Partnerships Team, London, EC1V 4AD, United Kingdom.
  • Trivier E; Cancer Research UK's Commercial Partnerships Team, London, EC1V 4AD, United Kingdom.
  • Sabin V; Cancer Research UK's Commercial Partnerships Team, London, EC1V 4AD, United Kingdom.
  • Gee JM; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, CF10 3NB, United Kingdom.
  • Sims AH; Applied Bioinformatics of Cancer Group, University of Edinburgh Cancer Research Centre, Edinburgh, EH4 2XR, United Kingdom.
  • Howell SJ; Breast Biology Group, Manchester Breast Centre, Division of Cancer Sciences, Oglesby Cancer Research Building, University of Manchester, Manchester, M20 4GJ, United Kingdom; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom.
  • Clarke RB; Breast Biology Group, Manchester Breast Centre, Division of Cancer Sciences, Oglesby Cancer Research Building, University of Manchester, Manchester, M20 4GJ, United Kingdom. Electronic address: robert.clarke@manchester.ac.
Cancer Lett ; 458: 66-75, 2019 08 28.
Article en En | MEDLINE | ID: mdl-31121213
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Células Madre Neoplásicas / Neoplasias de la Mama / Receptores de Estrógenos / Antineoplásicos Hormonales / Quinasas p21 Activadas Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Cancer Lett Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Células Madre Neoplásicas / Neoplasias de la Mama / Receptores de Estrógenos / Antineoplásicos Hormonales / Quinasas p21 Activadas Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Cancer Lett Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido